Singular Genomics Systems Inc

OMIC | $0.4144 6.9K

(0.0% 1d) (-18.8% 1m) (-59.0% 1y) (0.0% 2d) (2.5% 3d) (2.5% 7d) (77.63% volume)
Earnings Calendar: 2024-03-18
Market Cap: $ 30,701,029
https://singulargenomics.com
Sec Filling | Patents | 138 employees

Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics’ products in development and Singular Genomics’ core product tenets: accuracy, speed, flexibility and scale. Singular Genomics’ first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution.

t-cell

add to watch list Paper trade email alert is off

Press-releases

Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-18 (Crawled : 20:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| -25.1% | O: 4.13% H: 0.0% C: -9.89%
genomics year financial results

Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
Published: 2024-03-04 (Crawled : 21:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| -29.32% | O: 5.0% H: 0.0% C: -8.21%
report genomics year financial results

Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
Published: 2024-02-05 (Crawled : 16:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| -26.79% | O: 3.57% H: 2.4% C: -0.17%
genomics platform

Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
Published: 2024-02-05 (Crawled : 16:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| -26.79% | O: 3.57% H: 2.4% C: -0.17%
genomics

Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
Published: 2024-01-07 (Crawled : 00:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| -4.67% | O: -3.37% H: 12.61% C: 4.93%
genomics revenue

Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
Published: 2023-11-14 (Crawled : 21:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| 11.11% | O: -9.21% H: 17.91% C: 17.91%
genomics financial results

Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023
Published: 2023-10-24 (Crawled : 20:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| 13.95% | O: 0.06% H: 5.56% C: 3.61%
report genomics financial results

Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase
Published: 2023-09-08 (Crawled : 12:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| -7.41% | O: -0.54% H: 6.72% C: -0.09%
genomics group growth

Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial Results
Published: 2023-08-09 (Crawled : 20:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| -41.51% | O: 2.71% H: 4.15% C: -5.56%
genomics financial results

Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
Published: 2023-08-08 (Crawled : 20:00) - globenewswire.com
OMIC | $0.4144 6.9K

Professional, Scientific, and T...

| -43.84% | O: 0.0% H: 4.78% C: -3.97%
LH M | $206.1 -0.9% 110K

Health Services

| -4.6% | O: 0.48% H: 1.5% C: 0.61%
genomics

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001209191-24-004953	4	2024-03-19	2024-03-15	Sell	M	4187	50250
0001209191-24-004953	4	2024-03-19	2024-03-15	Buy	M	4187	16750
0001209191-24-004952	4	2024-03-19	2024-03-15	Sell	M	6250	75000
0001209191-24-004952	4	2024-03-19	2024-03-15	Buy	M	6250	200273
0001209191-24-004950	4	2024-03-19	2024-03-15	Sell	M	7500	90000
0001209191-24-004950	4	2024-03-19	2024-03-15	Buy	M	7500	4585000
0001209191-24-004948	4	2024-03-19	2024-03-15	Sell	M	14583	175000
0001209191-24-004948	4	2024-03-19	2024-03-15	Buy	G	14583	4090372
0001209191-24-004948	4	2024-03-19	2024-03-15	Sell	G	14583	9766
0001209191-24-004948	4	2024-03-19	2024-03-15	Buy	M	14583	24349